FDA Inspection 1001312 — Children's Hospital of Philadelphia

Children's Hospital of Philadelphia — FEI 2571772

The FDA completed an inspection of Children's Hospital of Philadelphia on February 16, 2017 in Philadelphia, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 16, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Philadelphia, PA (United States)